Product Information
GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET is a generic product labeled by AmerisourceBergen, priced at $0.1058 per EA under NDC 46122074268. Its NADAC has been published 127 times since Mar 20, 2024.
FDA first approved this application on Aug 1, 2023.
Strength
250; 125 mg/1; mg/1
Manufacturer
AmerisourceBergenNDC
46122074268
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA216999FDA Approved
8/1/2023
On Market Since
9/8/2023
Pharmacological Classes
Price Statistics
The NADAC for GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET has been published 127 times since Mar 20, 2024, and over the history we have for it it has risen 67.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1058 per EA |
|---|---|
| All-time high | $0.1086 (Jul 16, 2025) |
| All-time low | $0.0610 (May 22, 2024) |
| 52-week high | $0.1058 |
| 52-week low | $0.0839 |
| Median price | $0.0894 |
| Average price | $0.0863 |
| Largest weekly change | +15.2% (Jul 17, 2024) |
| Weeks tracked | 127 |
| Tracking since | Mar 20, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET, manufactured by AmerisourceBergen, is $0.1058 per EA (NDC 46122074268), effective Aug 19, 2026.
How has the price of GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET changed over time?
Over the history we have for it, the NADAC for GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET has risen 67.8%. It has been tracked across 127 weekly CMS publications since Mar 20, 2024.
What are the highest and lowest recorded NADAC prices for GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET?
Since Mar 20, 2024, the NADAC for GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET has ranged from a low of $0.0610 (May 22, 2024) to a high of $0.1086 (Jul 16, 2025), with a median of $0.0894 per EA.
Are there cheaper alternatives to GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET, is $0.0844 per EA — about 20% below GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET.
Who manufactures GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET?
GNP ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET (NDC 46122074268) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.